Clinical Trial Update: A Phase III Study of TMC435 in Treatment-naive, Genotype 1, Hepatitis C-infected Patients [Phase 3]

View source ↗

Summary

This clinical trial update reports results from a Phase III study of TMC435 in treatment-naive patients with chronic Hepatitis C genotype 1; the trial has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• TMC435

Snippet

Sponsor: Janssen Pharmaceutical K.K. | Conditions: Hepatitis C, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2013-12-09